Join AGP Ventures on Sept. 20 at 8:30 p.m. Israel time for a conversation with Brand Elverston and Myron Burke on “retail pain points.” Elverston and Burke spent more than two decades at Walmart, and have extensive experience addressing profit erosion at big-box retailers. We'll discuss major headaches (i.e., organized retail fraud) and explore areas of opportunity for Israeli startups and defense-technology companies. Join now.
We recently hosted a livestream with Dr. Justin Graham, who is head of informatics and clinical strategy at Walmart's secretive incubator, known as Store No. 8. The former Chief Innovation Officer at Hearst Health, Dr. Graham also worked at Anthem and has served as Chief Medical Office for several startups. We discussed approaches to innovation success in healthcare, and more. Click here to replay the conversation.
Our latest livestream in June was with Gary Briggs, who most recently served as Chief Marketing Officer Facebook. A board member of several public companies, including PetCo and Etsy, Gary discussed major trends in the U.S. consumer marketing space, and ways that Israeli startups can capitalize on those opportunities (and can avoid common pitfalls). Click here to replay the session.
We recently hosted a livestream with April Bertram, Director of Product Management in the Smart Building and Workplace Solutions groups at the $66 billion Lenovo. During the session, we discussed the future of work, smart building, and other topics of relevance to Israeli startups. Click here to replay the session.
We recently hosted a livestream conversation with Mark Nitkey, who was most recently Head of Store Design at Amazon Fresh. Nitkey, who held similar senior roles at Apple, CVS Health, Ahold, Banana Republic, The Gap and other retailers, discussed the future of retail, and explored opportunities for Israeli startups. Click here to replay it.
We recently hosted a livestream featuring Gil Moran, Vice President and Head of Direct-to-Consumer and Media Strategy at the National Football League. Gil discussed some of the NFL's business challenges, how the NFL works with startups, and the criteria he uses to asses whether a startup is ready to work with the NFL. If you missed the session and want to learn more, contact AGP partner Scott Cohen.
We recently held a conversation with Adam Schouela, Head of Emerging Technology at the Fidelity Center for Applied Technology. At FCAT, Schouela leads an international team of technologists who focus on rapidly building both products and PoCs across a wide range of technologies, from blockchain and AI to AR. If you missed the session and want to learn more about what Fidelity is working on, and how they work with Israeli startups, contact AGP partner Scott Cohen.
We recently held an intimate conversation with Uber Health's first-ever Chief Medical Officer, Dr. Michael Cantor. Dr. Cantor, who is leading development of new technologies and partnerships focused on access to care, briefed Israeli startups on key opportunities and priorities for Uber Health. If you missed the session and want to learn more, contact AGP partner Scott Cohen.
We spoke to senior executives at the top hospital systems and insurance companies in the U.S., and identified three opportunities that may run counter to assumptions and predictions propagated by pundits, consultants, and so-called “experts” in the startup community, including other venture capital firms. Read more.
Recent Webcast on successfully partnering with U.S. corporations.
This webcast has been concluded, but in April 2022 we hosted an exclusive conversation with award-winning journalist, reporter, and innovation expert Scott Kirsner, who shared insights and data from a report he conducted with MIT on the changing landscape of corporate-startup engagement. If you're interested in learning about what was covered, contact AGP partner Scott Cohen.
The recent news that there are 70+ Israeli unicorns is, quite simply, staggering. This development is fueling a massive geoeconomic orientation towards Tel Aviv — one with unique opportunities and challenges for U.S. startups, corporations, venture capital firms, and policymakers. Read more.
An FDA-primer for Israeli digital health startups: What you need to know.
This webcast was concluded, but we recently hosted a remarkable session with Steven Silverman, former compliance chief at the FDA's medical device center, and former head of FDA and regulatory affairs at the largest medical device association in the U.S. If you missed it, contact AGP partner Scott Cohen.
Six opportunities for Israeli ecommerce startups, from an executive at Wayfair.
This webcast was concluded, but we recently hosted an informative session with Matt Zisow, Vice President and Global Head of Consumer Product, Design and Analytics at Wayfair. Matt described six transformational opportunities he's been tracking, each of which were relevant to Israeli core capabilities. If you missed it, contact AGP partner Scott Cohen.
While the research and insights in this brief document were published during the heart of the pandemic, in early 2020, many of the predictions made still hold true. As such, they represent ongoing opportunities for Israeli startups we've been re-validating with U.S. enterprises on a regular basis. Read more.
Exec at $285B Unitedhealth Group on opportunities for Israeli healthcare startups.
This webcast was concluded, but we recently hosted an informative session with Richard Dale, the president of OptumLabs, which is the innovation and R&D center inside one of the largest healthcare players in the world. Richard discussed, among other things, his innovation priorities and needs. If you missed it, contact AGP partner Scott Cohen.
This research and insight was published during the heart of the pandemic, in April 2020. We keep it available online, as we believe it showcases lessons for the U.S. healthcare system from Israel's coordinated response, which integrated expertise from the defense, intelligence and healthcare sectors. It also provided three specific examples of technologies having immediate impact. Read more.